A new gene therapy treatment called Casgevy has been approved for patients with severe thalassaemia in England. This therapy offers hope for a cure and a better quality of life for hundreds with this debilitating blood disorder, predominantly affecting those of Mediterranean, Asian, or Middle Eastern heritage.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing